Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Swain

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
Investigational New Drugs|January 1, 1995
A phase II trial of paclitaxel (Taxol) as first line treatment in advanced breast cancerS M Swain, S F Honig, M C Tefft, et al.
Cancer Investigation|January 1, 1991
Reimbursement for solid tumor autologous bone marrow transplantation trials: a strategy for ensuring continuation of a promising therapyT R Spitzer, S M Swain, M E Lippman, et al.
Breast Cancer Research and Treatment|July 1, 1989
Treatment of stage III breast cancer. A panel discussionW L McGuire, M D Abeloff, G N Hortobagyi, et al.
The Plant Journal : for Cell and Molecular Biology|March 1, 1997
The LS locus of pea encodes the gibberellin biosynthesis enzyme ent-kaurene synthase AT Ait-Ali, S M Swain, J B Reid, et al.
The New Phytologist|November 7, 2012
Modifications of a conserved regulatory network involving INDEHISCENT controls multiple aspects of reproductive tissue development in ArabidopsisP Kay, M Groszmann, J J Ross, et al.
Investigational New Drugs|January 1, 1995
Phase I trial of pentosan polysulfateS M Swain, B Parker, A Wellstein, et al.
Advances in Experimental Medicine and Biology|January 1, 1988
The treatment of metastatic breast cancer with 5-fluorouracil and leucovorinC J Allegra, G F Egan, J C Drake, et al.
The Plant Journal : for Cell and Molecular Biology|November 28, 2001
The role of SPY and its TPR domain in the regulation of gibberellin action throughout the life cycle of Petunia hybrida plantsA Izhaki, S M Swain, T S Tseng, et al.
NPJ Breast Cancer|December 14, 2023
Optimal adjuvant therapy in older (≥70 years of age) women with low-risk early-stage breast cancerM Chadha, J White, S M Swain, et al.
Journal of the National Cancer Institute|July 7, 1993
Detectable inhibition of heparin-binding growth factor activity in sera from patients treated with pentosan polysulfateB W Parker, S M Swain, G Zugmaier, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Investigational New Drugs|January 1, 1995
A phase II trial of paclitaxel (Taxol) as first line treatment in advanced breast cancerS M Swain, S F Honig, M C Tefft, et al.
Cancer Investigation|January 1, 1991
Reimbursement for solid tumor autologous bone marrow transplantation trials: a strategy for ensuring continuation of a promising therapyT R Spitzer, S M Swain, M E Lippman, et al.
Breast Cancer Research and Treatment|July 1, 1989
Treatment of stage III breast cancer. A panel discussionW L McGuire, M D Abeloff, G N Hortobagyi, et al.
The Plant Journal : for Cell and Molecular Biology|March 1, 1997
The LS locus of pea encodes the gibberellin biosynthesis enzyme ent-kaurene synthase AT Ait-Ali, S M Swain, J B Reid, et al.
The New Phytologist|November 7, 2012
Modifications of a conserved regulatory network involving INDEHISCENT controls multiple aspects of reproductive tissue development in ArabidopsisP Kay, M Groszmann, J J Ross, et al.
Investigational New Drugs|January 1, 1995
Phase I trial of pentosan polysulfateS M Swain, B Parker, A Wellstein, et al.
Advances in Experimental Medicine and Biology|January 1, 1988
The treatment of metastatic breast cancer with 5-fluorouracil and leucovorinC J Allegra, G F Egan, J C Drake, et al.
The Plant Journal : for Cell and Molecular Biology|November 28, 2001
The role of SPY and its TPR domain in the regulation of gibberellin action throughout the life cycle of Petunia hybrida plantsA Izhaki, S M Swain, T S Tseng, et al.
NPJ Breast Cancer|December 14, 2023
Optimal adjuvant therapy in older (≥70 years of age) women with low-risk early-stage breast cancerM Chadha, J White, S M Swain, et al.
Journal of the National Cancer Institute|July 7, 1993
Detectable inhibition of heparin-binding growth factor activity in sera from patients treated with pentosan polysulfateB W Parker, S M Swain, G Zugmaier, et al.
Pageof 8